The Clinical Research Coordinator II will manage the Wisconsin CADASIL study site. The incumbent will recruit, screen, select, and determine eligibility of research volunteer participants who may undergo activities such as neuropsychological assessment, lumbar puncture, blood draws, brain scans, behavioral assessments, neurological examinations and survey questions about quality of life and treatment opinions/decision-making. They will also ensure that all research protocols are followed and test results are recorded appropriately. They will oversee the biofluid lab to ensure safety protocols and operating procedures are followed. They will also be responsible for training new biofluid team members. The lab hires undergraduates to give them experience with a research study. The incumbent will assign activities and supervise their day-to-day work. This position may require some work to be performed in-person, onsite, at a designated campus work location. Some work may be performed remotely, at an offsite, non-campus work location Must live in or be willing to relocate to the Madison, WI area Monday through Friday 8:00am - 4:30pm, but may vary depending on study visit schedule Terminal, 12-month appointment This position has been identified as a position of trust with access to vulnerable populations. The selected candidate will be required to pass an initial caregiver check to be eligible for employment under the Wisconsin Caregiver Law and every four years Dr. Paulsen's research program supports research in rare forms of very early cognitive decline and dementia (i.e., CADASIL, Huntington's disease). Our research studies help develop and refine the tools that can be used in clinical trials to measure the effectiveness of treatment before the disease impacts daily life. We seek to develop measures, methods and models of disease onset and progression that facilitate interventions and treatment programs throughout the life course of disease from being healthy and living at risk to managing early brain dysfunction and mild cognitive declines, to preparing for disease progression with loss of control over emotional, organizational, motor, and cognitive processes. Starting treatment sooner may help delay the start of symptoms or slow down the progression of the disease. Some scientists think that treatments may be more likely to work when the brain is still healthy, rather than later in the disease when many brain cells are gone. We want to plan for future clinical trials by finding and tracking subtle but measurable changes in behavior, cognition, and emotional responses that occur before the more visible symptoms appear.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level